Yu Lingling, Liu Shiqin, Zheng Cuihong, Liu Wenhua, Wang Hua, Liang Fengxia, Lu Wei, Xu Shabei, Wang Wei
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, Hubei, China.
Acupuncture and Moxibustion Institution, College of Acupuncture and Moxibustion, Hubei University of Chinese Medicine/Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibustion, 1 Tanhualin Road, Wuhan, 430030, Hubei, China.
Trials. 2020 Sep 29;21(1):818. doi: 10.1186/s13063-020-04720-5.
Primary dysmenorrhea (PD) is a leading cause of dysmenorrhea among adolescent girls. Manual acupuncture may be considered as an effective treatment for PD, but high-quality evidence remains limited. This trial aims to evaluate the efficacy and safety of acupuncture for the prevention of PD as compared with sham acupuncture and usual care.
METHODS/DESIGN: This is a three-arm, randomized, controlled clinical trial in which the patients, assessors, and statisticians will be blinded. A total of 300 acupuncture-naive patients who were diagnosed as PD will be randomly allocated to the verum acupuncture, sham acupuncture, or usual care groups in a 2:2:1 ratio. Patients in the verum acupuncture group will receive manual acupuncture at specific acupuncture points with penetrating needling, while those in the sham acupuncture group will receive non-penetrating needling at non-acupuncture points. They will be given five sessions over a menstrual cycle for 3 menstrual cycles. Patients in the usual care group will receive health education and informed to receive manual acupuncture for free after waiting for 7 menstrual cycles. The primary outcome will be the change from baseline in the Cox Menstrual Symptom Scale Score (CMSS). The secondary outcomes will be the changes in Massachusetts General Hospital Acupuncture Sensation Scale (MASS), visual analog scale (VAS), Short-Form McGill Pain Questionnaire 2 (SF-MPQ-2), Pittsburgh Sleep Quality Index (PSQI), Beck Anxiety Inventory (BAI), Beck Depression Inventory II (BDI- II), Acupuncture Expectancy Scale (AES), 60-item NEO Personality Inventory-Short Form (NEO-FFI), and acute medication intake. The adverse events will be recorded at every visit. The analyses will be performed base on a full analysis set (FAS) and a per-protocol set (PPS).
This study may provide high-quality evidence regarding the efficacy and safety of manual acupuncture for PD. In addition, the results of this study will help to identify the efficacy of acupuncture due to the specific effects of acupuncture or placebo effects of acupuncture ritual.
Clinical Trials.gov NCT02783534 . Registered on 26 May 2016.
原发性痛经(PD)是青春期女孩痛经的主要原因。手动针刺可被视为治疗PD的一种有效方法,但高质量证据仍然有限。本试验旨在评估针刺与假针刺及常规护理相比预防PD的疗效和安全性。
方法/设计:这是一项三臂、随机、对照临床试验,患者、评估者和统计人员将采用盲法。总共300名初诊为PD的未接受过针刺治疗的患者将按2:2:1的比例随机分配到真针刺组、假针刺组或常规护理组。真针刺组患者将在特定穴位采用透刺法接受手动针刺,而假针刺组患者将在非穴位处采用非透刺法。她们将在一个月经周期内接受5次治疗,共3个月经周期。常规护理组患者将接受健康教育,并被告知在等待7个月经周期后可免费接受手动针刺。主要结局将是考克斯月经症状量表评分(CMSS)相对于基线的变化。次要结局将是麻省总医院针刺感觉量表(MASS)、视觉模拟量表(VAS)、简化麦吉尔疼痛问卷2(SF-MPQ-2)、匹兹堡睡眠质量指数(PSQI)、贝克焦虑量表(BAI)、贝克抑郁量表第二版(BDI-II)、针刺期望量表(AES)、大五人格量表简版(NEO-FFI)60项以及急性药物摄入量的变化。每次就诊时记录不良事件。分析将基于全分析集(FAS)和符合方案集(PPS)进行。
本研究可能提供关于手动针刺治疗PD的疗效和安全性的高质量证据。此外,本研究结果将有助于确定针刺疗效是由于针刺的特定效应还是针刺仪式的安慰剂效应。
ClinicalTrials.gov NCT02783534。于2016年5月26日注册。